Raúl Romero Cano
About Raúl Romero Cano
Raúl Romero Cano is the Health Economics and Value Proposition Sr. Manager for the Hemato, Hemato-Oncology, and Immunology Franchise at Bristol Myers Squibb in CDMX, with extensive experience in health economics, market access, and medical affairs.
Current Title and Role
Raúl Romero Cano currently serves as the Health Economics and Value Proposition Sr. Manager for the Hemato, Hemato-Oncology, and Immunology Franchise at Bristol Myers Squibb. He is based in CDMX and focuses on the strategic and tactical planning for the inclusion of Hematology and Immunology products in the Mexican Health Technology Assessment (HTA) and private market.
Professional Experience
Raúl has accumulated extensive experience in health economics and medical sciences. He previously worked as HEOR Sr. Manager at Bristol Myers Squibb from 2018 to 2021. Before that, he was Health Economics and Value Assessment Manager at Sanofi from 2016 to 2018. His earlier roles include Secretario de comunicación at AMEIFAC, MSL Manager/Medical Manager at Sanofi, Medical Science Liaison for Diabetes at AstraZeneca, and Site Manager at Probiomed, S.A. de C.V.
Educational Background
Raúl Romero Cano holds a Master's degree in Health Economics from Universitat Pompeu Fabra, achieved in 2018. He earned a Master's degree in Health Science and a degree in Clinical Pharmacology from Universidad Nacional Autónoma de México. Additionally, he completed a Bachelor of Medicine (M.B.B.S.) in Clinical Research from Universidad Tominaga Nakamoto.
Key Skills and Expertise
Raúl brings a robust set of skills in health economics, market access, medical and scientific relations, and medical affairs. He has expertise in developing pharmacoeconomic models for low incidence and high-cost therapies and adapts global models to local contexts, facilitating the inclusion of new therapies in the Mexican healthcare system. His work focuses on creating value proposition strategies that address unmet medical needs while being economically efficient for payers.